Literature DB >> 22659891

Sacrificing the pulmonary arterial branch to the spared lobe is a risk factor of bronchopleural fistula in sleeve lobectomy after chemoradiotherapy.

Shinichi Toyooka1, Junichi Soh, Kazuhiko Shien, Seiichiro Sugimoto, Masaomi Yamane, Takahiro Oto, Hiroshi Date, Shinichiro Miyoshi.   

Abstract

OBJECTIVES: A sleeve lobectomy is a widely accepted procedure for enabling the pulmonary parenchyma to be spared. Induction chemoradiotherapy (CRT) followed by surgery is one treatment option for locally advanced non-small cell lung cancer (NSCLC), but CRT is considered to have a negative effect on subsequent surgery, especially for anastomotic healing. In this study, we describe our experience performing sleeve lobectomies and the associated anastomotic complications after induction CRT.
METHODS: The medical records of NSCLC patients who underwent surgery after receiving CRT were reviewed. The relationships between anastomotic complications and clinicopathological factors were examined.
RESULTS: Between December 1998 and October 2011, a total of 104 patients received CRT followed by surgery. Among them, 14 NSCLC patients underwent a bronchial sleeve resection: nine patients underwent a right upper lobe resection, two patients underwent a left lingular division and lower lobe resection and one patient each underwent a right lower lobe, a right upper and middle lobe and a right middle and lower lobe resection. A bronchopleural fistula at the anastomosis occurred in two patients. A pulmonary arterial (PA) branch to the spared lobe had been sacrificed in both of these patients because of tumour involvement. In contrast, the PA branches to the spared lobes were preserved in 11 of the 12 patients who did not exhibit anastomotic complications (P = 0.033).
CONCLUSIONS: Our experience strongly suggests that the sacrifice of the PA branch to the spared lobe is a possible risk factor for anastomotic complications for a sleeve lobectomy after induction CRT.

Entities:  

Mesh:

Year:  2012        PMID: 22659891     DOI: 10.1093/ejcts/ezs323

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  5 in total

1.  Induction chemoradiotherapy is superior to induction chemotherapy for the survival of non-small-cell lung cancer patients with pathological mediastinal lymph node metastasis.

Authors:  Shinichi Toyooka; Katsuyuki Kiura; Kazuhiko Shien; Kuniaki Katsui; Katsuyuki Hotta; Susumu Kanazawa; Hiroshi Date; Shinichiro Miyoshi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-09-12

2.  Surgical Techniques of Y-Sleeve Lobectomy in Patients With Primary Lung Cancer.

Authors:  Takuma Tsukioka; Nobuhiro Izumi; Hiroaki Komatsu; Hidetoshi Inoue; Ryuichi Ito; Noritoshi Nishiyama
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

3.  Risk factors and outcomes of bronchopleural fistula after bronchoplasty in patients with non-small cell lung cancer: a retrospective multivariate analysis.

Authors:  Zhiyu Peng; Jiandong Mei; Chengwu Liu; Chenglin Guo; Michel Gonzalez; Servet Bölükbas; Luca Voltolini; Qiang Pu; Lunxu Liu
Journal:  Transl Lung Cancer Res       Date:  2022-05

4.  Extended sleeve lobectomy after induction chemoradiotherapy for non-small cell lung cancer.

Authors:  Shinichi Toyooka; Junichi Soh; Hiromasa Yamamoto; Masaomi Yamane; Shigeru Hattori; Kazuhiko Shien; Kentaroh Miyoshi; Seiichiro Sugimoto; Takahiro Oto; Shinichiro Miyoshi
Journal:  Surg Today       Date:  2014-09-12       Impact factor: 2.549

5.  Is Surgery after Chemoradiotherapy Feasible in Lung Cancer Patients with Superior Vena Cava Invasion?

Authors:  Hiroki Sato; Junichi Soh; Katsuyuki Hotta; Kuniaki Katsui; Susumu Kanazawa; Katsuyuki Kiura; Shinichi Toyooka
Journal:  Ann Thorac Cardiovasc Surg       Date:  2018-04-20       Impact factor: 1.520

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.